Page last updated: 2024-08-20
dextrothyroxine and bortezomib
dextrothyroxine has been researched along with bortezomib in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Feng, Y; Gao, Q; Huang, J; Li, L; Li, Q; Lin, Z; Liu, X; Luo, H; Niu, T; Wang, F; Wang, X; Wen, J; Zhai, X; Zhang, L; Zhang, Y; Zheng, Y | 1 |
Other Studies
2 other study(ies) available for dextrothyroxine and bortezomib
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma.
Topics: Animals; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Disease Models, Animal; Humans; Ivermectin; Mice; Multiple Myeloma; Proteasome Endopeptidase Complex; Proteasome Inhibitors | 2023 |